Evidence map›Paper›PMID 41384108›Full record

ArticleFrontiers in medicine2025

Case Report: Difficulties in diagnosis of myeloid sarcoma of the breast by core needle biopsy.

Demian Wu, Xiaolan Li, Xiaoxue Tian, Ting Xu, Qiyao Ge, Shuai Luo, Jinjing Wang

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Demian WuDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Xiaolan LiDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Xiaoxue TianDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Ting XuDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Qiyao GeClass 3, Clinical Medicine, Grade 2023, Guizhou Medical University, Guiyang, Guizhou, China.
Shuai LuoDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Jinjing WangDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Myeloid sarcoma (MS) is a rare neoplasm that arises from myeloid blasts outside the bone marrow. Diagnosing and treating MS in the breast can be challenging due to its rarity in this location. Clinicians should consider MS when a breast mass is detected to implement appropriate treatment and avoid unnecessary surgery. Case demonstration: A 25-year-old female with a 2-year history of acute myeloid leukemia and a 1-year history of hematopoietic stem cell transplantation was admitted due to bilateral breast masses present for 1 month. Breast MRI plain scan + enhancement revealed bilateral breast masses with irregular shapes, irregular borders, and significant enhancement, suggesting a malignant tumor. A bilateral breast biopsy was performed, and the pathological diagnosis confirmed MS involving the breast. Following the diagnosis, local radiotherapy was performed, and no recurrence was observed during the 1-month follow-up. Conclusion: The clinical manifestations of MS in the breast are typically nonspecific, and its imaging features resemble those of breast cancer or other malignant tumors. Therefore, diagnosing primary MS of the breast without a history of leukemia is challenging, and the final diagnosis requires a histopathological biopsy. For patients with a history of AML, imaging should be regularly reviewed for early detection, diagnosis, and treatment to improve prognosis.

Indexed as

acute myeloid leukemiamyeloid sarcomapathologythe mammary glandtreatment

Identifiers

PMID41384108
PMCPMC12689335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.